General Motors Corporation (NYSE:GM): Citigroup raised its price target for General Motors citing lower pension underfunding following the company’s Q4 results. The firm remains positive on GM shares with a Buy rating.
Baidu, Inc. (NASDAQ:BIDU): Morgan Stanley said Chinese SMEs, which are Baidu (NASDAQ:BIDU) customers, are facing challenges that include rising costs and funding issues that will act as an overhang for Baidu. Shares are Equal Weight rated. Macquarie said Baidu reported an inline Q4 and Q1 guidance with a strong pick-up in mobile search. The firm rolled out its price target to 2013 and reiterates its Outperform rating.
Genesee & Wyoming Inc.(NYSE:GWR): Deutsche Bank views the recent 11% pullback in Genesee & Wyoming shares as providing a great entry point into the name. The firm reiterates a Buy rating on the stock with a $72 price target.
BioMarin Pharmaceutical Inc.(NASDAQ:BMRN): William Blair attributes weakness in BioMarin’s Q4 results and guidance to previously announced Naglazyme ordering patterns from Brazil. The firm said it would be a buyer of the stock on any pullback post the results and maintains an Outperform rating on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com